Triamcinolone Acetonide — Drug Intelligence | 21 EU Trials

Filter these 21 trials by condition, phase, country and more.

Open in Search →

21 Registered trials

11 Recruiting

6 Completed trials

15 Sponsors

18 Countries

Phase III

Phase II

Phase IV

Phase III: 8 Phase II/III: 1 Phase II: 3 Phase III/IV: 1 Phase IV: 8

Oversight events:

1 temporary halt 2 corrective measures across 3 trials

View oversight register →

Indications tested

Polymyositis 2 Retinitis pigmentosa 2 Dermatomyositis 2 Vertigo 1 Carpal tunnel syndrome 1 Idiopathic inflammatory myopathy 1 Otitis media 1 Tympanic membrane perforation 1 Endolymphatic hydrops 1 Tinnitus 1 Dizziness 1 Meniere's disease 1

Sponsors using this IMP

Janssen - Cilag International 3 Diakonhjemmet Sykehus AS 2 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 2 Inmunotek S.L. 2 Pfizer Inc. 2 Beacon Therapeutics (USA) Inc. 1 Eli Lilly & Co. 1 Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer 1 Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau 1 Leiden University Medical Center 1 Mater Misericordiae University Hospital 1 Medical University Of Vienna 1

All trials

21 total

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pig… Not authorised

2024-511181-36-00 Phase III 1 country Beacon Therapeutics (USA) Inc.
Filgotinib bridging in newly diagnosed rheumatoid arthritis patients (FAST RA trial); A pragmatic randomized controlled non-inferiority low … Pending

2024-517112-30-00 Phase IV 1 country Medisch Spectrum Twente
LOCAL INVASIVE TREATMENT OF TRAPEZIUS MUSCLE PAIN IN PATIENTS WITH FIBROMYALGIA Pending

2024-520345-23-00 Phase IV 1 country Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
C0251006 - A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN … Recruiting

2022-502739-20-00 Phase III 10 countries Pfizer Inc.
A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated all… Recruiting

2025-524580-21-00 Phase II/III 1 country Inmunotek S.L.
Frozen shoulder – can physiotherapy improve the outcome? Recruiting

2024-519728-26-00 Phase IV 1 country Oslo University Hospital HF
Comparing postoperative recovery after vitrectomy using NSAID eyedrops versus steroid eyedrops Recruiting

2024-518807-23-00 Phase IV 1 country UZ Leuven
An open-label extension study with dazukibart for participants with idiopathic inflammatory myopathies (including DM or PM) who have complet… Recruiting

2024-514648-10-00 Phase III 6 countries Pfizer Inc.
Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 … Recruiting

2022-500747-21-00 Phase II 11 countries Janssen - Cilag International
EFFICACY OF SUPRASPINATUS NERVE APPROACH THROUGH CORTICOSTEROID ADMINISTRATION VERSUS PULSED RADIOFREQUENCY IN CHRONIC SHOULDER PAIN. DOUBLE… Recruiting

2024-519892-24-00 Phase III 1 country Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Intracochlear Triamcinolone acetonide in sudden sensorineural hearing loss patients - a prospective observer blinded randomized study Recruiting

2024-513145-36-00 Phase II 1 country Medical University Of Vienna
STEPS-EA trial Recruiting

2023-504905-36-00 Phase III/IV 5 countries Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Painful Inflammatory Carpometacarpal-1 osteoArthritis treated with intraarticular Steroids, Saline or an Occupational therapy intervention: … Recruiting

2023-505254-17-00 Phase IV 1 country Diakonhjemmet Sykehus AS
Treatment of Menière's disease with intratympanic methylprednisolone (PREDMEN trial) Recruiting

2023-503340-13-00 Phase III 1 country Leiden University Medical Center
Comparing the effectiveness of our tailor-made management approach with routine care from a clinical, patient's as well as an economic point… Ended

2024-511530-12-01 Phase IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Long Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defec… Ended

2024-511411-25-00 Phase III 6 countries Janssen Cilag International
NOR-CACTUS Ended

2024-511223-34-00 Phase IV 1 country Diakonhjemmet Sykehus AS
Is botulinum toxin injection better than corticosteroid injection in the management of persistent post-surgical pain Halted

2024-518954-18-01 Phase IV 1 country Mater Misericordiae University Hospital
A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered sub… Ended

2024-515717-17-00 Phase III 1 country Inmunotek S.L.
A study to evaluate Intravitreal JNJ-81201887(AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary… Ended

2022-500746-16-00 Phase II 11 countries Janssen - Cilag International
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis (BREEZE-AD-PEDS) Ended

2023-503898-38-00 Phase III 7 countries Eli Lilly & Co.

Showing 1–21 of 21 trials

← All drugs A–Z